These few pharmaceutical stocks have been quite "safe" lately... $Johnson & Johnson(JNJ.US) got sued over its ads, $Pfizer(PFE.US) had its rating and target price slashed pretty hard, and $Merck(MRK.US) is also facing a patent cliff. Holding onto those tiny gains, the mindset is becoming more and more like waiting for retirement. But biotech has had some weird volatility these past few days. $Direxion S&P Biotech Bull 3X(LABU.US), which was getting hammered for days, actually bounced a bit today, so swing traders are probably getting a little hopeful again. $SPDR S&P Biotech(XBI.US) is seeing big divergence, with money flowing in on the dip. Those still holding it have already adopted a zen attitude: it's not about which naive investor falls faster now, it's about who can hold out longer... Just holding on, Buddha-style.